Immune Therapy Plus Chemotherapy Erases Stage IIIB Lung Tumor Before Surgery
A stage IIIB lung squamous cell carcinoma patient achieved a pathological complete response after neoadjuvant sugemalimab plus chemotherapy, with biomarker ...
A stage IIIB lung squamous cell carcinoma patient achieved a pathological complete response after neoadjuvant sugemalimab plus chemotherapy, with biomarker ...
A multi-omics study finds that LDL cholesterol metabolism reshapes macrophages and tumor cells in head and neck squamous cell carcinoma, ...
A high tumor mutational burden detected by liquid biopsy guided nivolumab treatment that produced a durable complete remission in a ...
A case report describes the first hepatoid adenocarcinoma of the lung harboring a POLE P286R mutation, which drove hypermutation, mismatch ...
Researchers developed a random forest model integrating six clinical, inflammatory and molecular predictors that forecasts immunotherapy response in advanced lung ...
A Swiss genomic study of muscle-invasive bladder cancer finds that oncogene amplifications, rather than tumor mutational burden or microsatellite instability, ...
A new review argues that neoadjuvant chemoradiotherapy may induce immune checkpoint blockade responsiveness in mismatch repair-proficient rectal cancer, with sequential ...
New TORCH trial data show that combining SMAD4 mutation status, tumor mutational burden, and serial ctDNA with MRI assessments substantially ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine